Jan 5, 2026 07:30AM
Dec 30, 2025 03:34PM
Dec 30, 2025 03:33PM
Dec 18, 2025 12:34PM
Dec 18, 2025 12:29PM
Dec 18, 2025 12:29PM
Dec 18, 2025 07:30AM Cybin to Transfer U.S. Stock Exchange Listing to Nasdaq
Nov 13, 2025 07:20AM
Nov 12, 2025 07:30AM
Nov 6, 2025 07:30AM
Nov 5, 2025 07:30AM
Nov 3, 2025 07:30AM
Oct 31, 2025 04:19PM
Oct 31, 2025 04:19PM Cybin Announces Closing of $175 Million Registered Direct Offering
Oct 28, 2025 08:00AM
Oct 28, 2025 08:00AM
Sep 23, 2025 05:00PM
Sep 23, 2025 05:00PM
Sep 11, 2025 07:30AM
Sep 8, 2025 07:30AM
Sep 8, 2025 07:30AM Cybin Completes Enrollment in Phase 2 Study Evaluating CYB004 for the Treatment of Generalized Anxiety Disorder
Sep 4, 2025 07:30AM
Sep 3, 2025 07:30AM
Sep 2, 2025 07:30AM
Sep 2, 2025 07:30AM
Aug 26, 2025 07:30AM
Aug 18, 2025 05:30PM
Aug 13, 2025 05:30PM Cybin Reports Important Progress on Key Milestones and First Quarter Fiscal Year 2026 Financial Results
Aug 7, 2025 07:30AM
Aug 7, 2025 07:30AM
Jul 17, 2025 07:30AM
Jul 17, 2025 07:30AM
Jul 1, 2025 11:19AM
Jul 1, 2025 09:50AM
Jun 30, 2025 10:03PM Cybin Reports Fiscal Year 2025 Financial Results and Recent Business Highlights
Jun 30, 2025 09:27PM
Jun 13, 2025 07:45AM
Jun 13, 2025 07:45AM
Jun 3, 2025 07:31AM
Jun 3, 2025 07:30AM
May 22, 2025 07:30AM
May 20, 2025 07:32AM Cybin Inc (CYBN) Applauds FDA Commissioner Dr. Martin Makary’s Call to Accelerate and Prioritize Research on Psychedelic Therapeutics
May 20, 2025 07:30AM
May 15, 2025 07:31AM
May 15, 2025 07:30AM
May 8, 2025 07:30AM
May 8, 2025 07:30AM
May 1, 2025 07:30AM
Apr 23, 2025 07:30AM Cybin Inc (CYBN) Announces Additional Strategic Clinical Site Partnerships to Support PARADIGM
Apr 23, 2025 07:30AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All